Ironwood Pharmaceuticals Inc - Ordinary Shares - Class A
IRWD
Market Cap$118.27M
Close$
$20.34
2736.6% upside
Current Fair Value
2736.6% upsideUndervalued by 2736.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $118.27 Million |
|---|---|
| Enterprise Value | $229.70 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $0.01 |
| Beta | 0.23 |
| Outstanding Shares | 160,974,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -3.75 |
|---|---|
| PEG | -0.47 |
| Price to Sales | 0.72 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.72 |
| Enterprise Value to EBIT | 4.17 |
| Enterprise Value to Net Income | 6 |
| Total Debt to Enterprise | 0.96 |
| Debt to Equity | 3.22 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Ironwood Pharmaceuticals Inc
CEO: Mark Mallon